HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-JAN-11 3QGH TITLE CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA TITLE 2 POLYMERASE GENOTYPE 1A COMPLEX WITH N-CYCLOPROPYL-6-[(3R)-3-{[4- TITLE 3 (TRIFLUOROMETHOXY)BENZYL]CARBAMOYL}-4-{[4-(TRIFLUOROMETHOXY) TITLE 4 PHENYL]SULFONYL}PIPERAZIN-1-YL]PYRIDAZINE-3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.48; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS SUBTYPE 1A; SOURCE 3 ORGANISM_TAXID: 31646; SOURCE 4 STRAIN: BARTENSCHLAGER; SOURCE 5 GENE: NS5B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS NS5B, POLYMERASE, HCV, FINGERS, PALM, THUMB, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 2 13-SEP-23 3QGH 1 REMARK SEQADV REVDAT 1 20-APR-11 3QGH 0 JRNL AUTH R.G.GENTLES,S.SHERIFF,B.R.BENO,C.WAN,K.KISH,M.DING,X.ZHENG, JRNL AUTH 2 L.CHUPAK,M.A.POSS,M.R.WITMER,P.MORIN,Y.K.WANG,K.RIGAT, JRNL AUTH 3 J.LEMM,S.VOSS,M.LIU,L.PELOSI,S.B.ROBERTS,M.GAO,J.F.KADOW JRNL TITL INVESTIGATION OF THE MODE OF BINDING OF A NOVEL SERIES OF JRNL TITL 2 N-BENZYL-4-HETEROARYL-1-(PHENYLSULFONYL) JRNL TITL 3 PIPERAZINE-2-CARBOXAMIDES TO THE HEPATITIS C VIRUS JRNL TITL 4 POLYMERASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2212 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21441029 JRNL DOI 10.1016/J.BMCL.2011.03.011 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 38805 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.780 REMARK 3 FREE R VALUE TEST SET COUNT : 1077 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.69 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2921 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1642 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2827 REMARK 3 BIN R VALUE (WORKING SET) : 0.1617 REMARK 3 BIN FREE R VALUE : 0.2413 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 94 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4294 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.07700 REMARK 3 B22 (A**2) : -1.66300 REMARK 3 B33 (A**2) : -2.41400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.197 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.189 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.158 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.174 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.153 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4462 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6070 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1496 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 78 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 661 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4462 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : 7 ; 0.000 ; HARMONIC REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 582 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5595 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.25 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QGH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38895 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.16600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : 0.51500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: DERIVED FROM PDB ENTRY 3Q0Z, NS5B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% (W/V) PEG 8000, 40 MM POTASSIUM REMARK 280 PHOSPHATE, 20% (V/V) GLYCEROL, PH 7.3, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.65000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.45000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.45000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.65000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 0 REMARK 465 GLY A 152 REMARK 465 GLY A 153 REMARK 465 HIS A 562 REMARK 465 SER A 563 REMARK 465 VAL A 564 REMARK 465 SER A 565 REMARK 465 HIS A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 47 CG CD OE1 NE2 REMARK 470 LYS A 77 CE NZ REMARK 470 LYS A 100 CD CE NZ REMARK 470 GLN A 148 CG CD OE1 NE2 REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 LYS A 151 CG CD CE NZ REMARK 470 GLN A 206 CG CD OE1 NE2 REMARK 470 GLN A 441 CG CD OE1 NE2 REMARK 470 SER A 548 OG REMARK 470 SER A 556 OG REMARK 470 ILE A 560 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 260 -56.98 -139.41 REMARK 500 SER A 347 56.10 71.51 REMARK 500 ALA A 348 58.27 -149.09 REMARK 500 ILE A 424 -63.54 -103.49 REMARK 500 ILE A 560 -111.52 -44.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 63F A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 651 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 652 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 653 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 654 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 655 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QGD RELATED DB: PDB REMARK 900 RELATED ID: 3QGE RELATED DB: PDB REMARK 900 RELATED ID: 3QGF RELATED DB: PDB REMARK 900 RELATED ID: 3QGG RELATED DB: PDB REMARK 900 RELATED ID: 3QGI RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE UNIPROT ENTRY B1PBP5_9HEPC DOES NOT PROVIDE THE COMPLETE REMARK 999 SEQUENCE. THE COMPLETE SEQUENCE CAN BE FOUND IN THE NCBI ENTRY NP_ REMARK 999 751928.1. DBREF 3QGH A 1 568 UNP B1PBP5 B1PBP5_9HEPC 475 1042 SEQADV 3QGH ALA A 0 UNP B1PBP5 EXPRESSION TAG SEQADV 3QGH PRO A 569 UNP B1PBP5 SEE REMARK 999 SEQADV 3QGH ARG A 570 UNP B1PBP5 SEE REMARK 999 SEQRES 1 A 571 ALA SER MET SER TYR SER TRP THR GLY ALA LEU VAL THR SEQRES 2 A 571 PRO CYS ALA ALA GLU GLU GLN LYS LEU PRO ILE ASN ALA SEQRES 3 A 571 LEU SER ASN SER LEU LEU ARG HIS HIS ASN LEU VAL TYR SEQRES 4 A 571 SER THR THR SER ARG SER ALA CYS GLN ARG GLN LYS LYS SEQRES 5 A 571 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP SER HIS TYR SEQRES 6 A 571 GLN ASP VAL LEU LYS GLU VAL LYS ALA ALA ALA SER LYS SEQRES 7 A 571 VAL LYS ALA ASN LEU LEU SER VAL GLU GLU ALA CYS SER SEQRES 8 A 571 LEU THR PRO PRO HIS SER ALA LYS SER LYS PHE GLY TYR SEQRES 9 A 571 GLY ALA LYS ASP VAL ARG CYS HIS ALA ARG LYS ALA VAL SEQRES 10 A 571 ALA HIS ILE ASN SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 A 571 SER VAL THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 A 571 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 A 571 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 A 571 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER LYS SEQRES 15 A 571 LEU PRO LEU ALA VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 A 571 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL GLN ALA SEQRES 17 A 571 TRP LYS SER LYS LYS THR PRO MET GLY PHE SER TYR ASP SEQRES 18 A 571 THR ARG CYS PHE ASP SER THR VAL THR GLU SER ASP ILE SEQRES 19 A 571 ARG THR GLU GLU ALA ILE TYR GLN CYS CYS ASP LEU ASP SEQRES 20 A 571 PRO GLN ALA ARG VAL ALA ILE LYS SER LEU THR GLU ARG SEQRES 21 A 571 LEU TYR VAL GLY GLY PRO LEU THR ASN SER ARG GLY GLU SEQRES 22 A 571 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 A 571 THR THR SER CYS GLY ASN THR LEU THR CYS TYR ILE LYS SEQRES 24 A 571 ALA ARG ALA ALA CYS ARG ALA ALA GLY LEU GLN ASP CYS SEQRES 25 A 571 THR MET LEU VAL CYS GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 A 571 GLU SER ALA GLY VAL GLN GLU ASP ALA ALA SER LEU ARG SEQRES 27 A 571 ALA PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 A 571 GLY ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 A 571 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP GLY SEQRES 30 A 571 ALA GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 A 571 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 A 571 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET PHE SEQRES 33 A 571 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 A 571 PHE PHE SER VAL LEU ILE ALA ARG ASP GLN LEU GLU GLN SEQRES 35 A 571 ALA LEU ASN CYS GLU ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 A 571 GLU PRO LEU ASP LEU PRO PRO ILE ILE GLN ARG LEU HIS SEQRES 37 A 571 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 A 571 GLU ILE ASN ARG VAL ALA ALA CYS LEU ARG LYS LEU GLY SEQRES 39 A 571 VAL PRO PRO LEU ARG ALA TRP ARG HIS ARG ALA ARG SER SEQRES 40 A 571 VAL ARG ALA ARG LEU LEU SER ARG GLY GLY ARG ALA ALA SEQRES 41 A 571 ILE CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL ARG THR SEQRES 42 A 571 LYS LEU LYS LEU THR PRO ILE ALA ALA ALA GLY ARG LEU SEQRES 43 A 571 ASP LEU SER GLY TRP PHE THR ALA GLY TYR SER GLY GLY SEQRES 44 A 571 ASP ILE TYR HIS SER VAL SER HIS ALA ARG PRO ARG HET 63F A 601 47 HET PO4 A 651 5 HET PO4 A 652 5 HET PO4 A 653 5 HET PO4 A 654 5 HET PO4 A 655 5 HETNAM 63F N-CYCLOPROPYL-6-[(3R)-3-{[4-(TRIFLUOROMETHOXY) HETNAM 2 63F BENZYL]CARBAMOYL}-4-{[4-(TRIFLUOROMETHOXY) HETNAM 3 63F PHENYL]SULFONYL}PIPERAZIN-1-YL]PYRIDAZINE-3- HETNAM 4 63F CARBOXAMIDE HETNAM PO4 PHOSPHATE ION FORMUL 2 63F C28 H26 F6 N6 O6 S FORMUL 3 PO4 5(O4 P 3-) FORMUL 8 HOH *430(H2 O) HELIX 1 1 ASN A 24 LEU A 31 1 8 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 CYS A 110 1 7 HELIX 8 8 ALA A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 SER A 180 1 17 HELIX 10 10 LYS A 181 GLY A 188 1 8 HELIX 11 11 SER A 189 TYR A 195 5 7 HELIX 12 12 SER A 196 SER A 210 1 15 HELIX 13 13 CYS A 223 VAL A 228 1 6 HELIX 14 14 THR A 229 GLN A 241 1 13 HELIX 15 15 ASP A 246 LEU A 260 1 15 HELIX 16 16 THR A 286 GLY A 307 1 22 HELIX 17 17 GLY A 328 TYR A 346 1 19 HELIX 18 18 ASP A 359 ILE A 363 5 5 HELIX 19 19 PRO A 388 ARG A 401 1 14 HELIX 20 20 ASN A 406 PHE A 415 1 10 HELIX 21 21 THR A 418 ILE A 424 1 7 HELIX 22 22 ILE A 424 ARG A 436 1 13 HELIX 23 23 GLU A 455 LEU A 457 5 3 HELIX 24 24 ASP A 458 GLY A 468 1 11 HELIX 25 25 LEU A 469 SER A 473 5 5 HELIX 26 26 SER A 478 GLY A 493 1 16 HELIX 27 27 PRO A 496 GLY A 515 1 20 HELIX 28 28 GLY A 515 PHE A 526 1 12 HELIX 29 29 ASN A 527 VAL A 530 5 4 HELIX 30 30 ILE A 539 LEU A 545 1 7 HELIX 31 31 ASP A 546 PHE A 551 1 6 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N SER A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N THR A 136 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O ILE A 160 N MET A 139 SHEET 1 B 2 VAL A 37 SER A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 CYS A 316 -1 N GLN A 309 O GLU A 325 SHEET 1 D 2 ASN A 369 HIS A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 E 3 LEU A 443 ILE A 447 0 SHEET 2 E 3 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SHEET 3 E 3 THR A 552 TYR A 555 -1 O ALA A 553 N CYS A 451 SITE 1 AC1 23 VAL A 179 TYR A 191 GLY A 192 PHE A 193 SITE 2 AC1 23 TYR A 195 SER A 196 PRO A 197 ARG A 200 SITE 3 AC1 23 SER A 288 CYS A 289 SER A 368 ILE A 413 SITE 4 AC1 23 MET A 414 PHE A 415 ILE A 447 TYR A 448 SITE 5 AC1 23 TYR A 452 ILE A 454 ILE A 462 LEU A 547 SITE 6 AC1 23 PHE A 551 TYR A 555 HOH A 971 SITE 1 AC2 7 ARG A 32 HIS A 33 GLU A 237 GLN A 241 SITE 2 AC2 7 LYS A 254 HOH A 907 HOH A 938 SITE 1 AC3 6 ARG A 48 LYS A 51 ARG A 222 CYS A 223 SITE 2 AC3 6 HOH A 897 HOH A1009 SITE 1 AC4 4 ARG A 505 VAL A 530 ARG A 531 THR A 532 SITE 1 AC5 8 GLN A 19 TYR A 38 SER A 39 THR A 40 SITE 2 AC5 8 THR A 41 SER A 44 ARG A 154 HOH A1015 SITE 1 AC6 6 ARG A 48 VAL A 52 ARG A 158 LEU A 159 SITE 2 AC6 6 HOH A 886 HOH A1023 CRYST1 61.300 84.700 132.900 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016313 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011806 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007524 0.00000